The five latest EBMT papers published in peer-reviewed journals
Effect of the Thiotepa Dose in the TBF Conditioning Regimen in Patients Undergoing Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in Complete Remission: A Report From the EBMT Acute Leukemia Working Party.
El-Cheikh J et al
Clin Lymphoma Myeloma Leuk.
Pediatric acute graft-versus-host disease prophylaxis and treatment: Real-life approach reveals dissimilarities compared to published recommendations.
Lawitschka A et al
Transpl Int.
Long-term outcome after allogeneic hematopoietic stem cell transplantation for Shwachman-Diamond syndrome: a retrospective analysis and a review of the literature by the Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation (SAAWP-EBMT).
Cesaro S et al
Bone Marrow Transplant.
Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy?-A multicenter EBMT-PDWP study.
Willasch AM et al
Bone Marrow Transplant.
Alternative donors provide comparable results to matched unrelated donors in patients with acute lymphoblastic leukemia undergoing allogeneic stem cell transplantation in second complete remission: a report from the EBMT Acute Leukemia Working Party.
Brissot E et al
Bone Marrow Transplant.
Top cited papers published in Bone Marrow Transplantation
The European Society for Blood and Marrow Transplantation (EBMT) consensus recommendations for donor selection in haploidentical hematopoietic cell transplantation
Stefan O. Ciurea, Monzr M. Al Malki, Piyanuch Kongtim et al
Autologous haematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases: updated guidelines and recommendations from the EBMT Autoimmune Diseases Working Party (ADWP) and the Joint Accreditation Committee of EBMT and ISCT (JACIE)
Basil Sharrack, Riccardo Saccardi, Tobias Alexander et al
Cord blood research, banking, and transplantation: achievements, challenges, and perspectives
Hector Mayani, John E. Wagner & Hal E. Broxmeyer
Features of Toxoplasma gondii reactivation after allogeneic hematopoietic stem-cell transplantation in a high seroprevalence setting
Olivier Paccoud, Juliette Guitard, Myriam Labopin et al
Pre-hematopoietic cell transplant Ruxolitinib in patients with primary and secondary myelofibrosis
Rachel B. Salit, Bart L. Scott, Emily A. Stevens et al